Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayrettin Guven

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Medicine|March 18, 2014
Decreased decorin expression in the tumor microenvironmentBenedek Bozoky, Andrii Savchenko, Hayrettin Guven, et al.
International Journal of Cancer|March 8, 2012
The architecture of fibroblast monolayers of different origin differentially influences tumor cell growthEmilie Flaberg, Hayrettin Guven, Andrii Savchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependentTwana Alkasalias, Emilie Flaberg, Vladimir Kashuba, et al.
British Journal of Haematology|April 25, 2009
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical studyWendy Ingram, Lucas Chan, Hayrettin Guven, et al.
Experimental Hematology|November 3, 2005
Efficient gene transfer into primary human natural killer cells by retroviral transductionHayrettin Guven, Kyriakos V Konstantinidis, Evren Alici, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 18, 2015
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growthAndrey Alexeyenko, Twana Alkasalias, Tatiana Pavlova, et al.
Immunotherapy|July 20, 2010
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical studyLisbeth Barkholt, Evren Alici, Reka Conrad, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Medicine|March 18, 2014
Decreased decorin expression in the tumor microenvironmentBenedek Bozoky, Andrii Savchenko, Hayrettin Guven, et al.
International Journal of Cancer|March 8, 2012
The architecture of fibroblast monolayers of different origin differentially influences tumor cell growthEmilie Flaberg, Hayrettin Guven, Andrii Savchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependentTwana Alkasalias, Emilie Flaberg, Vladimir Kashuba, et al.
British Journal of Haematology|April 25, 2009
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: implications for a phase I clinical studyWendy Ingram, Lucas Chan, Hayrettin Guven, et al.
Experimental Hematology|November 3, 2005
Efficient gene transfer into primary human natural killer cells by retroviral transductionHayrettin Guven, Kyriakos V Konstantinidis, Evren Alici, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 18, 2015
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growthAndrey Alexeyenko, Twana Alkasalias, Tatiana Pavlova, et al.
Immunotherapy|July 20, 2010
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical studyLisbeth Barkholt, Evren Alici, Reka Conrad, et al.
Pageof 1